What to expect: Same active ingredient (semaglutide), different manufacturing pathway. Transition to equivalent dose. Verify Wegovy formulary status before switching.
Washout window: None — same active ingredient
Why patients switch from Compounded semaglutide to Wegovy
- FDA resolved Wegovy shortage (October 2024) — compounding restrictions tightening
- Insurance now covering Wegovy under obesity indication
- FDA-approved finished product offers full regulatory oversight
- 503A/503B compounding pharmacies facing enforcement action
- Consistency of dose + sterility guarantees
Side effects during the Compounded semaglutide → Wegovy transition
- Typically none — same molecule
- Possible injection site differences (Wegovy pen vs vial+syringe)
- Brief GI re-adjustment if dose stepped up
Discuss with your prescriber before switching
This guide is editorial — not medical advice. Switching GLP-1 medications must be supervised. Bring this checklist to your appointment:
- Required — confirm Wegovy prior authorization approval
- If insurance denies Wegovy, document compounded as bridge
- If pregnant or planning pregnancy (Wegovy has REMS-like prescribing requirements)
Dose conversion: Compounded semaglutide → Wegovy
Use this table as a starting reference only. Final dose depends on your tolerance, weight-loss trajectory, and prescriber guidance. Never self-titrate based on a chart.
| Compounded semaglutide dose | Wegovy dose | Note |
|---|---|---|
| 0.25 mg/week | 0.25 mg/week | Starting dose — identical |
| 0.5 mg/week | 0.5 mg/week | — |
| 1 mg/week | 1 mg/week | — |
| 1.7 mg/week | 1.7 mg/week (Wegovy only) | — |
| 2 mg/week | 2.4 mg/week (Wegovy max) | — |
Transition timeline
Plan on 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark on the new medication.
Week −2: Decision + prescriber alignment
Confirm with your prescriber: dose-equivalent target, expected side-effect profile differences (semaglutide → semaglutide), insurance implications.
Week −1: Last Compounded semaglutide dose
Continue your current Compounded semaglutide schedule. Compounded semaglutide has a long half-life — semaglutide ~1 week, tirzepatide ~5 days — so effects persist for days after stopping.
Week 0: First Wegovy dose
Start Wegovy at your equivalent dose (see table below). Combined effect may be elevated in the first week as Compounded semaglutide clears.
Weeks 1-4: Stabilization
Side-effect profile shifts. Adjust to new effect onset timing. Track weight + appetite.
Weeks 4-12: Re-evaluation
Compare outcomes to your Compounded semaglutide baseline. If weight-loss trajectory hasn't improved by week 12, discuss whether the switch was right.
Beyond 12 weeks
If outcomes good, continue. If switch underperformed Compounded semaglutide, discuss reverting or trying a third option (often tirzepatide-based).
FAQ — Compounded semaglutide → Wegovy
Can I take Compounded semaglutide and Wegovy together?
No. Both contain semaglutide — taking them together is effectively double-dosing the same medication. Stop Compounded semaglutide before starting Wegovy.
Will I lose ground when switching from Compounded semaglutide to Wegovy?
Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Compounded semaglutide efficacy. Plan and 12-week evaluation window.
Does insurance cover Wegovy if it covered Compounded semaglutide?
Wegovy is FDA-approved — insurance coverage is more typical. Verify formulary status and whether prior authorization is required for Wegovy specifically.
How long does Compounded semaglutide stay in my system after the last dose?
Semaglutide has a ~1-week half-life — effects taper over 4-5 weeks after the last injection. Plan your Wegovy start timing accordingly.
Cost comparison
Cash-pay pricing differs significantly between Compounded semaglutide and Wegovy. Run the true-cost calculator with your insurance details for an apples-to-apples comparison including coupons and patient assistance programs. Open true cost calculator →
Provider match
Find a provider that offers Wegovy
Continuity of care matters during a switch. We compared 12+ telehealth providers ranked by Wegovy availability, price, and prescriber accessibility.
See top Wegovy providers →Affiliate disclosure: we earn commission on provider sign-ups. Learn more
Next steps
Before switching, read our full Compounded semaglutide review and Wegovy review. For provider options that carry both medications, see our Compounded semaglutide vs Wegovy comparison and Compounded semaglutide alternatives hub.
Sources
Not medical advice. Switching GLP-1 medications must be done with prescriber supervision. This guide is editorial summary based on published prescribing information and clinical guidance. Full medical disclaimer.